Controlled cortical impact injury influences methylphenidate-induced changes in striatal dopamine neurotransmission

Journal of Neurochemistry

Volumn 110, Issue 3, 2009, Pages 801-810

  Wagner, Amy K ^a,b,c   Sokoloski, Joshua E ^a,b   Chen, Xiangbai ^a,b   Harun, Rashed ^a,b,c   Clossin, Damian P ^a,b   Khan, Amina S ^a,c   Andes Koback, Meghan ^a,c   Michael, Adrian C ^c   Dixon, C Edward ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Controlled cortical impact; Dopamine transporter; Electrochemistry; Methylphenidate; Microdialysis; Voltammetry

Indexed keywords

DOPAMINE; METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; MALE; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

ANIMALS; BRAIN INJURIES; CORPUS STRIATUM; DOPAMINE; ELECTROCHEMISTRY; MALE; METHYLPHENIDATE; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION; TIME FACTORS;

RATTUS;

EID: 67650484193     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06155.x     Document Type: Article

References (50)

1. Abin-Carriquiry J. A., Costa G., Urbanavicius J., Cassels B. K., Rebolledo-Fuentes M., Wonnacott S. Dajas F. (2008) In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's disease. Eur. J. Pharmacol. 589, 80 84.
2. Arnsten A. F. (2006) Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology 31, 2376 2383. Review. (Pubitemid 44607054)
3. Borland L. M. Michael A. C. (2004) Voltammetric study of the control of striatal dopamine release by glutamate. J. Neurochem. 91, 220 229. (Pubitemid 39314952)
4. Borland L. M., Shi G., Yang H. Michael A. C. (2005) Voltammetric study of extracellular dopamine near microdialysis probes acutely implanted in the striatum of the anesthetized rat. J. Neurosci. Methods 146, 149 158. (Pubitemid 41373452)
5. Brandon C. L. Steiner H. (2003) Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum. Eur. J. Neurosci. 18, 1584 1592. (Pubitemid 37215111)
6. Butcher S. P., Liptrot J. Aburthnott G. W. (1991) Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci. Lett. 122, 245 248.
7. Chase T. D., Brown R. E., Carrey N. Wilkinson M. (2003) Daily methylphenidate administration attenuates c-fos expression in the striatum of prepubertal rats. Neuroreport 14, 769 772. (Pubitemid 36570939)
8. Dash P. K., Moore A. N. Dixon C. E. (1995) Spatial memory deficits, increased phosphorylation of the transcription factor CREB, and induction of the AP-1 complex following experimental brain injury. J. Neurosci. 15, 2030 2039.
9. Dixon C. E., Clifton G. L., Lighthall J. W., Yaqhmai A. A. Hayes R. L. (1991) A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods 39, 253 262.
10. Dunn-Meynell A. A. Levin B. E. (1997) Histological markers of neuronal, axonal and astrocytic changes after lateral rigid impact traumatic brain injury. Brain Res. 761, 25 41. (Pubitemid 27314730)
11. Fleckenstein A. E., Volz T. J. Hanson G. R. (2008) Psychostimulant- induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications. Neuropharmacology 56, 131 138.
12. Gagnaire F., Chalansonnet M., Carabin N. Micillino J. C. (2006) Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain. Arch. Toxicol. 80, 703 712. (Pubitemid 44394531)
13. Graybiel A. M., Moratalla R. Robertson H. A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl Acad. Sci. USA 87, 6912 6916.
14. Greco P. G. Garris P. A. (2003) In vivo interaction of cocaine with the dopamine transporter as measured by voltammetry. Eur. J. Pharmacol. 479, 117 125. Review. (Pubitemid 37377881)
15. Hawken C. M., Brown R. E., Carrey N. Wilkinson M. (2004) Long-term methylphenidate treatment down-regulates c-fos in the striatum of male CD-1 mice. Neuroreport 15, 1045 1048. (Pubitemid 38591259)
16. Hope B., Kosofsky B., Hyman S. E. Nestler E. J. (1992) Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. Natl Acad. Sci. USA 89, 5764 5768.
17. Hope B. T., Simmons D. E., Mitchell T. B., Kreuter J. D. Mattson B. J. (2006) Cocaine-induced locomotor activity and Fos expression in nucleus accumbens are sensitized for 6 months after repeated cocaine administration outside the home cage. Eur. J. Neurosci. 24, 867 875. (Pubitemid 44232530)
18. Huff J. K. Davies M. I. (2002) Microdialysis monitoring of methylphenidate in blood and brain correlated with changes in dopamine and rat activity. J. Pharm. Biomed. Anal. 29, 767 777. (Pubitemid 34692592)
19. Jedynak J. P., Ali S. F., Haycock J. W. Hope B. T. (2002) Acute administration of cocaine regulates the phosphorylation of serine-19, -31 and -40 in tyrosine hydroxylase. J. Neurochem. 82, 382 388. (Pubitemid 34774629)
20. Kaakkola S., Männistö P. T. Nissinen E. (1987) Striatal membrane-bound and soluble catechol-O-methyl-transferase after selective neuronal lesions in the rat. J. Neural Transm. 69, 221 228.
21. Kline A. E., Yan H. Q., Bao J., Marion D. W. Dixon C. E. (2000) Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neurosci. Lett. 280, 163 166. (Pubitemid 30089826)
22. Kuczenski R. Segal D. S. (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 68, 2032 2037. (Pubitemid 27176139)
23. Kuczenski R. Segal D. S. (2005) Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biol. Psychiatry 57, 1391 1396. Review. (Pubitemid 40798560)
24. Kulgina N. V., Zigmond M. J. Michael A. C. (2001) Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience 19, 121 128. (Pubitemid 32171858)
25. Lin J. S., Hou Y. Jouvet M. (1996) Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc. Natl Acad. Sci. USA 93, 14128 14133. (Pubitemid 26424257)
26. Lonjon M., Quentien M. H., Risso J. J., Michiels J. F., Carre E., Rostain J. C. Darbin O. (2004) Alteration of striatal dopaminergic function induced by glioma development: a microdialysis and immunohistological study in the rat striatum. Neurosci. Lett. 354, 131 134. (Pubitemid 38032851)
27. Lu Y., Peters J. L. Michael A. C. (1998) Direct comparison of the response of voltammetry and microdialysis to electrically evoked release of striatal dopamine. J. Neurochem. 70, 584 593. (Pubitemid 28079347)
28. Massucci J. L., Kline A. E., Ma X., Zafonte R. D. Dixon C. E. (2004) Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats. Neurosci. Lett. 372, 127 131. (Pubitemid 39505242)
29. McIntosh T. K., Yu T. Gennarelli T. A. (1994) Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J. Neurochem. 63, 1426 1433. (Pubitemid 24299529)
30. Natale J. E., Ahmed F., Cernak I., Stoica B. Faden A. I. (2003) Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. J. Neurotrauma 20, 907 927. (Pubitemid 37288552)
31. Oechsner M., Strauss J. Stuerenberg H. J. (2002) COMT-inhibition increases serum levels of dihydroxyphenylacetic acid (DOPAC) in patients with advanced Parkinson's disease. J. Neural Transm. 109, 69 75. (Pubitemid 34146590)
32. Paxinos G. Watson C. 1998) The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press, San Diego, CA.
33. Sadri-Vakili G., Janis G. C., Pierce R. C., Gibbs T. T. Farb D. H. (2008) Nanomolar concentrations of pregnenolone sulfate enhance striatal dopamine overflow in vivo. J. Pharmacol. Exp. Ther. 327, 840 845.
34. Shaham Y. Hope B. T. (2005) The role of neuroadaptations in relapse to drug seeking Nat. Neurosci. 8, 1437 1439. Review. (Pubitemid 41573651)
35. Smith A. D., Kozlowski D. A., Bohn M. C. Zigmond M. J. (2005) Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats. Exp. Neurol. 193, 420 426. (Pubitemid 40616190)
36. Tong W., Igarashi T., Ferriero D. M. Noble L. J. (2002) Traumatic brain injury in the immature mouse brain: characterization of regional vulnerability. Exp. Neurol. 176, 105 116. (Pubitemid 34762110)
37. Volz T. J., Farnsworth S. J., King J. L., Riddle E. L., Hanson G. R. Fleckenstein A. E. (2007) Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane associated vesicles. J. Pharmacol. Exp. Ther. 323, 738 745. (Pubitemid 350005143)
38. Volz T. J., Farnsworth S. J., Rowley S. D., Hanson G. R. Fleckenstein A. E. (2008) Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and D2 receptors. J. Pharmacol. Exp. Ther. 327, 161 167.
39. Wagner A. K., Sokoloski J. E., Ren D., Chen X., Khan A. S., Zafonte R. D., Michael A. C. Dixon C. E. (2005a) Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. J. Neurochem. 95, 457 465. (Pubitemid 41457514)
40. Wagner A. K., Chen X., Kline A. E., Li Y., Zafonte R. D. Dixon C. E. (2005b) Gender and environmental enrichment impact dopamine transporter expression after experimental traumatic brain injury. Exp. Neurol. 195, 475 483. (Pubitemid 41297798)
41. Wagner A. K., Ren D., Conley Y., Ma X., Kerr M. E., Zafonte R. D., Puccio A. M., Marion D. W. Dixon C. E. (2007a) Gender and genetic associations with CSF dopamine and metabolite production after severe TBI. J. Neurosurg. 106, 537 547.
42. Wagner A. K., Kline A. E., Ren D., Willard L. A., Wenger M. K., Zafonte R. D. Dixon C. E. (2007b) Gender associations with chronic methylphenidate treatment and behavioral performance following experimental TBI. Behav. Brain Res. 181, 200 209. (Pubitemid 46898657)
43. Wagner A. K., Drewencki L., Chen X., Santos F. R., Khan A. S., Harun R., Torres G., Michael A. C. Dixon C. E. (2009) Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury. J. Neurochem. 108, 986 997.
44. Warden D. L., Gordon B., McAllister T. W. et al. (2006) Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. J. Neurotrauma 23, 1468 1501. (Pubitemid 46489606)
45. Yan H. Q., Ma X., Chen X., Li Y., Shao L. Dixon C. E. (2007) Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury. Brain Res. 1134, 171 179. (Pubitemid 46135534)
46. Yang K., Mu X. S., Xue J. J., Whitson J., Salminen A., Dixon C. E., Liu P. K. Hayes R. L. (1994) Increased expression of c-fos mRNA and AP-1 transcription factors after cortical impact injury in rats. Brain Res. 664, 141 147. (Pubitemid 2161794)
47. Yano M. Steiner H. (2005) Topography of methylphenidate (ritalin)-induced gene regulation in the striatum: differential effects on c-fos, substance P and opioid peptides. Neuropsychopharmacology 30, 901 915. (Pubitemid 40570906)
48. Youdim M. Riederer P. F. (2004) A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's disease. Neurology 63, S32 S35.
49. Young S. T., Porrino L. J. Iadarola M. J. (1991) Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl Acad. Sci. USA 88, 1291 1295. (Pubitemid 21916210)
50. Zetterström T., Sharp T., Collin A. K. Ungerstedt U. (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148, 327 334. (Pubitemid 18101682)